2010
DOI: 10.1073/pnas.0908565107
|View full text |Cite
|
Sign up to set email alerts
|

Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I

Abstract: G41 is an interfacial residue located within the α-helix 34-42 of alanine:glyoxylate aminotransferase (AGT). Its mutations on the major (AGT-Ma) or the minor (AGT-Mi) allele give rise to the variants G41R-Ma, G41R-Mi, and G41V-Ma causing hyperoxaluria type 1. Impairment of dimerization in these variants has been suggested to be responsible for immunoreactivity deficiency, intraperoxisomal aggregation, and sensitivity to proteasomal degradation. However, no experimental evidence supports this view. Here we repo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
86
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 63 publications
(100 citation statements)
references
References 18 publications
13
86
0
1
Order By: Relevance
“…in the absence of the P11L replacement). Previous studies on purified recombinant AGT expressed in E. coli suggest that, except for G41R, they do not (18,21,34). Therefore it is likely that peroxisome-to-mitochondrion mistargeting caused by these mutations, all result from a similar synergistic interaction to that previously identified for G170R.…”
Section: Discussionmentioning
confidence: 76%
“…in the absence of the P11L replacement). Previous studies on purified recombinant AGT expressed in E. coli suggest that, except for G41R, they do not (18,21,34). Therefore it is likely that peroxisome-to-mitochondrion mistargeting caused by these mutations, all result from a similar synergistic interaction to that previously identified for G170R.…”
Section: Discussionmentioning
confidence: 76%
“…These results emphasize the incompletely penetrant nature/ variable expressivity of p.G170R and suggest a different pathomechanism for other MiR alleles, such as monomer aggregation or active site disruption, as indicated for p.G41R. 29,44 This is important in considering pyridoxine therapy for patients with other MiR alleles because this cofactor is thought to stabilize the monomer/dimer. Nevertheless, anecdotal evidence suggests pyridoxine response in a variety of AGXT mutation patients (including p.F152I or two truncating alleles), indicating that alternative therapeutic benefits of pyridoxine may exist (e.g., influence on gene expression and/or enzyme activity).…”
Section: Discussionmentioning
confidence: 82%
“…G41E and G41R, located at the dimerization interface of AGT, were included in this group. G41R has been characterized in depth in vitro, where it has been shown to affect dimerization, reduce affinity of AGT for PLP (Cellini et al 2010b), and significantly increase aggregation under physiological conditions. Molecular dynamics simulations of this mutant revealed unwinding of the 34-42 a-helix and displacement of the first 44 amino acid residues, including an active site loop at residues 24-32 (Cellini et al 2010b).…”
Section: Characterization Of Uncharacterized Disease Alleles Of Agtmentioning
confidence: 99%
“…G41R has been characterized in depth in vitro, where it has been shown to affect dimerization, reduce affinity of AGT for PLP (Cellini et al 2010b), and significantly increase aggregation under physiological conditions. Molecular dynamics simulations of this mutant revealed unwinding of the 34-42 a-helix and displacement of the first 44 amino acid residues, including an active site loop at residues 24-32 (Cellini et al 2010b). While not involved in coordinating PLP, Gly47 is also near the active site of the enzyme, and the replacement of the smaller glycine in the G47R variant may locally perturb the structure.…”
Section: Characterization Of Uncharacterized Disease Alleles Of Agtmentioning
confidence: 99%